CRIS Q3 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+16.5% YoY

Gross Profit

$3M94.6% margin

Operating Income

-$6M-225.4% margin

Net Income

-$7M-253.7% margin

EPS (Diluted)

$-4.36

QoQ Revenue Growth

+20.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$894,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$43M

Stockholders' Equity

$782,000

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+16.5%
Gross Profit	$3M	$2M	+16.1%
Operating Income	-$6M	-$14M	+55.7%
Net Income	-$7M	-$15M	+53.3%

Revenue Segments

Research and Development, Net

$100,00050%

Drug Development Royalty

$100,00050%